Innovative Product Offering Bio2 Medical's flagship product, the Angel Catheter, addresses a critical need for immediate PE prophylaxis and central venous access in ICU settings, providing a targeted solution that can appeal to hospitals and clinics prioritizing patient safety and efficient care.

Recent Asset Acquisition The sale of Bio2 Medical’s vascular device assets to Mermaid Medical indicates a strategic focus shift, presenting opportunities to collaborate or integrate with Mermaid’s expanding portfolio within vascular interventions or related markets.

Growth Potential With a revenue range of one to ten million dollars and ongoing funding, Bio2 Medical is positioned as an emerging player with room for growth, making it attractive for partnerships, licensing deals, or distribution agreements aiming to scale the Angel catheter.

Strategic Location & Certification Operating in US and UK markets from ISO 13485 certified facilities ensures compliance with international quality standards, enabling targeted sales efforts in North America, Europe, and markets with stringent medical device regulations.

Technology & Infrastructure Using advanced tech stacks and cloud infrastructure, Bio2 Medical demonstrates a strong commitment to innovation and operational efficiency, offering opportunities to leverage this technological foundation for joint development or integration initiatives.